Efficacy of the 308-nm Excimer Light in the Treatment of Psoriasis patient: A Case Report

Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol 2012; 26:29-35.

Hrehorow E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta DermVenereol 2012; 92:67-72.

Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005; 23:681-94.

Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58:826-50.

Reich A, Szepietowski J. Genetic and immunological aspects of the pathogenesis of psoriasis. Wiad Lek 2007; 60:270-6.

Ouyang W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev 2010; 21:435-41.

Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361:496-509.

“Questions and Answers about Psoriasis”. National Institute of Arthritis and Musculoskeletal and Skin Diseases. October 2013. Retrieved 1 July 2015.

Lima XT, Minnillo R, Spencer JM, Kimball AB. Psoriasis prevalence among the 2009 AAD National Melanoma/ Skin Cancer Screening Program participants. J Eur Acad Dermatol Venerol 2013; 27: 680-5.

Krisada Duangurai. Dermatological society of Thailand reveals that psoriasis is common disease. But the patients have very erroneous. [Internet]. [cited 2013 May 28]. Available from: http://www.thaipr.net/tag/psoriasis.

Photobiology unit, Institue of Dermatology, Department of Medical Services. Disease Statistics Report classified by psoriasis was treated with phototherapy; 2556

Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol 2007; 25: 535-46.

Weller, Richard, John AA Hunter, John Savin, Mark Dahl. Clinical dermatology. 4th ed. Malden, MA: Blackwell; 2008 p. 54-70.

Fischer T. UV-light treatment of psoriasis. Acta Derm Venereol 1976; 56: 473-79.

Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-62.

Van Weelden H, van der Leun JC. Improving the effectiveness of phototherapy for psoriasis.Br J Dermatol 1984; 111: 484.

Van Weelden H. De La Faille HB, Young E. van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119:11-9.

Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 2006; 24: 33-42.

Nistico S, Costanzo A, Saraceno R, ChimentiS. Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol 2004; 151: 877-9.

Vanessa Ngan, Staff Writer. Excimer 308-nm light treatment. Derm Net New Zealand 2006; 10: 241-48.

Kobayashi K, Yasuda Y, Shintani Y, Sumitomo T, Saga T, Kimura M, et al.The development of a filter to enhance the efficacy and safety of excimerlight (308 nm) therapy. Photodermatol Photoimmunol Photomed 2009; 25: 30-6.

Iga N, Otsuka A, Tanioka M, Miyachi Y, Kabashima K. Improvement of Anti-TNF-α Antibody-Induced Palmoplantar Pustular Psoriasis Using a 308-nm Excimer Light. Case Rep Dermatol 2012; 4: 261-4.

Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo. Clin Dermatol 2006; 24: 33-42.

Furuhashi T, Torii K, Kato H, Nishida, E Saito C, Morita A. Efficacy of excimer light therapy (308 nm) for palmoplantar pustulosis with the induction of circulating regulatory T cell. Exp Dermatol 2011; 20: 768-70.